Clinical significance of the lymph node ratio in N1 breast cancer.
- Published in:
- Radiation Oncology Journal, 2017, v. 35, n. 3, p. 227, doi. 10.3857/roj.2017.00101
- By:
- Publication type:
- Article
Works matching IS 22341900 AND DT 2017 AND VI 35 AND IP 3
Results: 13
1
2
Identification of CEA-interacting proteins in colon cancer cells and their changes in expression after irradiation.
- Published in:
- Radiation Oncology Journal, 2017, v. 35, n. 3, p. 281, doi. 10.3857/roj.2017.00255
- By:
- Publication type:
- Article
3
Refining prognostic stratification of human papillomavirus-related oropharyngeal squamous cell carcinoma: different prognosis between T1 and T2.
- Published in:
- Radiation Oncology Journal, 2017, v. 35, n. 3, p. 233, doi. 10.3857/roj.2017.00465
- By:
- Publication type:
- Article
4
Treatment outcome and risk analysis for cataract after radiotherapy of localized ocular adnexal mucosa-associated lymphoid tissue (MALT) lymphoma.
- Published in:
- Radiation Oncology Journal, 2017, v. 35, n. 3, p. 249, doi. 10.3857/roj.2017.00374
- By:
- Publication type:
- Article
5
Gross tumor volume dependency on phase sorting methods of four-dimensional computed tomography images for lung cancer.
- Published in:
- Radiation Oncology Journal, 2017, v. 35, n. 3, p. 274, doi. 10.3857/roj.2017.00444
- By:
- Publication type:
- Article
6
Effect of leukocyte alteration on treatment outcomes following preoperative chemoradiotherapy in patients with rectal cancer.
- Published in:
- Radiation Oncology Journal, 2017, v. 35, n. 3, p. 217, doi. 10.3857/roj.2017.00269
- By:
- Publication type:
- Article
7
Simultaneous integrated boost intensity-modulated radiotherapy versus 3-dimensional conformal radiotherapy in preoperative concurrent chemoradiotherapy for locally advanced rectal cancer.
- Published in:
- Radiation Oncology Journal, 2017, v. 35, n. 3, p. 208, doi. 10.3857/roj.2017.00353
- By:
- Publication type:
- Article
8
Multimodal therapy for locally advanced prostate cancer: the roles of radiotherapy, androgen deprivation therapy, and their combination.
- Published in:
- Radiation Oncology Journal, 2017, v. 35, n. 3, p. 189, doi. 10.3857/roj.2017.00318
- By:
- Publication type:
- Article
9
Role of fractionated radiotherapy in patients with hemangioma of the cavernous sinus.
- Published in:
- Radiation Oncology Journal, 2017, v. 35, n. 3, p. 268, doi. 10.3857/roj.2017.00199
- By:
- Publication type:
- Article
10
Factors associated with pulmonary toxicity after myeloablative conditioning using fractionated total body irradiation.
- Published in:
- Radiation Oncology Journal, 2017, v. 35, n. 3, p. 257, doi. 10.3857/roj.2017.00290
- By:
- Publication type:
- Article
11
Treatment outcomes of extended-field radiation therapy for thoracic superficial esophageal cancer.
- Published in:
- Radiation Oncology Journal, 2017, v. 35, n. 3, p. 241, doi. 10.3857/roj.2017.00458
- By:
- Publication type:
- Article
12
Preoperative chemoradiotherapy versus postoperative chemoradiotherapy for stage II-III resectable rectal cancer: a meta-analysis of randomized controlled trials.
- Published in:
- Radiation Oncology Journal, 2017, v. 35, n. 3, p. 198, doi. 10.3857/roj.2017.00059
- By:
- Publication type:
- Article
13
Radiation recall dermatitis triggered by sorafenib after radiation therapy for hepatocellular carcinoma.
- Published in:
- Radiation Oncology Journal, 2017, v. 35, n. 3, p. 289, doi. 10.3857/roj.2017.00339
- By:
- Publication type:
- Article